210 related articles for article (PubMed ID: 9424737)
1. [Functionality of von Willebrand factor present in Fanhdi: adhesion to the vascular subendothelium in vitro].
Escolar G; Viñas M; Pino M; Casamiquela R; Jorquera JI
Sangre (Barc); 1997 Oct; 42(5):377-81. PubMed ID: 9424737
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
4. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
5. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions.
Díaz-Ricart M; Estebanell E; Lozano M; Aznar-Salatti J; White JG; Ordinas A; Escolar G
Haematologica; 2000 Mar; 85(3):280-8. PubMed ID: 10702817
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
7. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
[TBL] [Abstract][Full Text] [Related]
8. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
[TBL] [Abstract][Full Text] [Related]
9. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
[TBL] [Abstract][Full Text] [Related]
10. Association between bleeding time and platelet adherence to artery subendothelium.
Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
[TBL] [Abstract][Full Text] [Related]
11. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.
Bolhuis PA; Sakariassen KS; Sander HJ; Bouma BN; Sixma JJ
J Lab Clin Med; 1981 Apr; 97(4):568-76. PubMed ID: 6782184
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
14. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
15. [No ELISA detectable alterations in immunogenicity following dry-hear treatment (72 hours at 80 degrees C) of FANHDI].
Bravo MI; Massot M; Jorquera JI
Sangre (Barc); 1999 Dec; 44(6):412-7. PubMed ID: 10822752
[TBL] [Abstract][Full Text] [Related]
16. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen and von Willebrand factor mediated platelet adhesion to polystyrene under flow conditions.
Zhang M; Wu Y; Hauch K; Horbett TA
J Biomater Sci Polym Ed; 2008; 19(10):1383-410. PubMed ID: 18854129
[TBL] [Abstract][Full Text] [Related]
18. An intermediate-purity factor VIII concentrate supports platelet adhesion under flow conditions.
Aznar-Salatti J; Escolar G; Arnau C; Carretero M; White JG; García-Barbal J; Castillo R; Ordinas A
Haemophilia; 1997 Jan; 3(1):14-20. PubMed ID: 27214613
[TBL] [Abstract][Full Text] [Related]
19. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]